Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.
Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.
Join us live: Tuesday 27th May, 18:00-19:15 (CEST)
Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.
Claire Paquet discusses the implications of the real-world and recommendation data presented on anti-amyloid antibody therapies for Alzheimer’s disease.
Gemma Salvadó, Sharon A Brangman, and Argonde van Harten explore what the latest developments from AAIC 2024 mean for clinical practice. How can blood-based biomarkers best be applied? What should you consider when selecting patients for amyloid-targeting therapies?
Dorota Religa and Robert Perneczky walk us through the most exciting findings from the AD/PD™ and CONy 2024 conferences. Their discussion focuses on existing and emerging biomarkers and new amyloid-targeting therapies in Alzheimer's disease.
Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.
Urologist James Catto asks oncologist Thomas Powles key questions on the role of ctDNA in the understanding of urothelial cancer and its potential to improve treatment decision-making in the future.
In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.
This content is intended only for US-based healthcare providers.
Watch an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies.
In this interactive webinar, a multidisciplinary team of speakers provide practical guidance on managing patients with cutaneous T-cell lymphoma. Learn about the key aspects of diagnosis and treatment via a series of patient cases.
Severe pain is the most common symptom of chronic pancreatitis. In this live webinar, experts shared the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discussed pertinent cases and provided practical suggestions for use within clinical practice.
In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
Watch as Dr. Sofia Rivera explains why the HypoG-01 trial will change how radiotherapy is administered in patients with locoregional early breast cancer.
Dive into the NIAGARA trial of perioperative durvalumab with Dr. Petros Grivas as he outlines the key findings and implications for managing muscle-invasive bladder cancer.
Watch as Prof. Domenica Lorusso outlines the positive overall survival data from KEYNOTE-A18, reinforcing the benefit of add-on pembrolizumab in locally advanced cervical cancer.
Dr. Sarah Derks takes us through the key studies in gastroesophageal, liver, and pancreatic cancer presented at ESMO 2024, discussing the results and clinical implications.
Dr. Ignacio Duran shares his highlights of the non-prostate genitourinary tumors presentations at ESMO 2024, and summarizes the most relevant new information about bladder and kidney cancer.
In this official video from the ESC 2024 Congress, Prof Niklaus Marx explains what every cardiologist needs to consider when working with patients with obesity. With a focus on the ESC consensus statement on obesity and CVD, Prof Marx offers useful tips for effective management of this increasingly common population in your cardiology clinic.
Dr. Rhian Touyz takes us through the main features of the new ESC guidelines on the management of elevated blood pressure and hypertension, including a new blood pressure category and more ambitious and intensive treatment targets.
Professor Lucia Mazzolai outlines the key recommendations from the new ESC guidelines on peripheral arterial and aortic diseases, such as the importance of screening, emphasis on exercise and lifestyle changes, and optimal pharmacological treatment.
Professor Dipak Kotecha gives an overview of the new ESC guidelines on atrial fibrillation, highlighting the importance of shared decision-making and the new AF-CARE pathway to optimize patient care.
Professor Pardeep Jhund shares the main findings of their meta-analysis of mineralocorticoid receptor antagonists in heart failure, based on data from the RALES, EMPHASIS-HF, TOPCAT, and FINEARTS-HF trials.
Professor Benjamin O'Brien discusses the TIGHT-K study results, which indicate that routine potassium supplementation can be avoided after isolated coronary artery bypass graft surgery.
Professor Johanne Silvain takes us through the main findings of the ABYSS study, which evaluated the safety of beta-blocker interruption versus continuation in people with a history of myocardial infarction.
